This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
September 27-30, 2022
Boston Convention and Exhibition CenterBoston, MA

Touchlight DNA Services

Profile

Touchlight provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA and DNA vaccines, alongside viral and non-viral gene therapy. Touchlight’s novel, synthetic DNA vector, doggybone DNA, is an antibiotic resistance free DNA vector with fast manufacturing timelines for research through to GMP applications. Clients can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house.